Citation: La. Jaber et Rl. Slaughter, EFFICACY OF INSULIN-METFORMIN COMBINATION THERAPY IN PATIENTS WITH TYPE-2 DIABETES-MELLITUS, Diabetes, 47, 1998, pp. 343-343
Authors:
SONNENBERG GE
GARG DC
WEIDLER DJ
DIXON RM
JABER LA
BOWEN AJ
DECHERNEY GS
MULLICAN WS
STONESIFER LD
Citation: Ge. Sonnenberg et al., SHORT-TERM COMPARISON OF ONCE-DAILY VERSUS TWICE-DAILY ADMINISTRATIONOF GLIMEPIRIDE IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS, The Annals of pharmacotherapy, 31(6), 1997, pp. 671-676
Citation: La. Jaber et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF GLYBURIDE IN YOUNG AND ELDERLY PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS, The Annals of pharmacotherapy, 30(5), 1996, pp. 472-475
Citation: Wr. Melchior et La. Jaber, METFORMIN - AN ANTIHYPERGLYCEMIC AGENT FOR TREATMENT OF TYPE-II DIABETES, The Annals of pharmacotherapy, 30(2), 1996, pp. 158-164
Authors:
JABER LA
DUCHARME MP
EDWARDS DJ
SLAUGHTER R
GRUNBERGER G
Citation: La. Jaber et al., THE INFLUENCE OF MULTIPLE DOSING AND AGE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF GLIPIZIDE IN PATIENTS WITH TYPE-II DIABETES-MELLITUS, Pharmacotherapy, 16(5), 1996, pp. 760-768
Citation: La. Jaber et al., THE EFFECTS OF OBESITY ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF GLIPIZIDE IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Therapeutic drug monitoring, 18(1), 1996, pp. 6-13
Citation: Pt. Calissi et La. Jaber, PERIPHERAL DIABETIC NEUROPATHY - CURRENT CONCEPTS IN TREATMENT, The Annals of pharmacotherapy, 29(7-8), 1995, pp. 769-777
Authors:
JABER LA
ANTAL EJ
SLAUGHTER RL
WELSHMAN IR
Citation: La. Jaber et al., COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF SHORT-TERM ANDLONG-TERM GLYBURIDE THERAPY IN NIDDM, Diabetes care, 17(11), 1994, pp. 1300-1306
Authors:
JABER LA
ANTAL EJ
SLAUGHTER RL
WELSHMAN IR
Citation: La. Jaber et al., COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF SHORT-TERM ANDLONG-TERM GLYBURIDE THERAPY IN NIDDM, Diabetes care, 17(11), 1994, pp. 1300-1306
Authors:
JABER LA
ANTAL EJ
SLAUGHTER RL
WELSHMAN IR
Citation: La. Jaber et al., THE PHARMACOKINETICS AND PHARMACODYNAMICS OF 12 WEEKS OF GLYBURIDE THERAPY IN OBESE DIABETICS, European Journal of Clinical Pharmacology, 45(5), 1993, pp. 459-463